JP2006522820A5 - - Google Patents

Download PDF

Info

Publication number
JP2006522820A5
JP2006522820A5 JP2006509872A JP2006509872A JP2006522820A5 JP 2006522820 A5 JP2006522820 A5 JP 2006522820A5 JP 2006509872 A JP2006509872 A JP 2006509872A JP 2006509872 A JP2006509872 A JP 2006509872A JP 2006522820 A5 JP2006522820 A5 JP 2006522820A5
Authority
JP
Japan
Prior art keywords
phenyl
imidazol
substituted
formula
seed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006509872A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006522820A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/011010 external-priority patent/WO2004091610A1/en
Publication of JP2006522820A publication Critical patent/JP2006522820A/ja
Publication of JP2006522820A5 publication Critical patent/JP2006522820A5/ja
Pending legal-status Critical Current

Links

JP2006509872A 2003-04-10 2004-04-09 アレルギーおよび過剰増殖疾患の治療のためのイミダゾール誘導体 Pending JP2006522820A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46209003P 2003-04-10 2003-04-10
PCT/US2004/011010 WO2004091610A1 (en) 2003-04-10 2004-04-09 Imidazole derivatives for treatment of allergic and hyperproliferative disorders

Publications (2)

Publication Number Publication Date
JP2006522820A JP2006522820A (ja) 2006-10-05
JP2006522820A5 true JP2006522820A5 (enExample) 2007-02-08

Family

ID=33299906

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006509872A Pending JP2006522820A (ja) 2003-04-10 2004-04-09 アレルギーおよび過剰増殖疾患の治療のためのイミダゾール誘導体

Country Status (15)

Country Link
US (1) US20040229927A1 (enExample)
EP (1) EP1613310A1 (enExample)
JP (1) JP2006522820A (enExample)
KR (1) KR20050120711A (enExample)
CN (1) CN1826111A (enExample)
AR (1) AR045886A1 (enExample)
AU (1) AU2004229466A1 (enExample)
BR (1) BRPI0409097A (enExample)
CA (1) CA2521841A1 (enExample)
MX (1) MXJL05000041A (enExample)
PL (1) PL378919A1 (enExample)
RU (1) RU2005134670A (enExample)
TW (1) TW200503695A (enExample)
WO (1) WO2004091610A1 (enExample)
ZA (1) ZA200508108B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919366B2 (en) * 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
PT1368028E (pt) * 2001-03-12 2007-11-26 Avanir Pharmaceuticals Compostos de benzimidazole para modulação de ige e inibição da proliferação celular
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
TWI276631B (en) * 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
WO2005013950A2 (en) * 2003-08-08 2005-02-17 Avanir Pharmaceuticals Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
MXPA06011021A (es) * 2004-03-25 2007-04-13 Johnson & Johnson Compuestos de imidazol.
BRPI0711358A2 (pt) * 2006-05-09 2011-09-27 Pfizer Prod Inc derivados do ácido cicloalquilamino e suas composições farmacêuticas
PE20080948A1 (es) * 2006-07-25 2008-09-10 Irm Llc Derivados de imidazol como moduladores de la senda de hedgehog
US9187485B2 (en) 2007-02-02 2015-11-17 Baylor College Of Medicine Methods and compositions for the treatment of cancer and related hyperproliferative disorders
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
US9334242B2 (en) 2008-06-16 2016-05-10 Gtx, Inc. Compounds for treatment of cancer
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
LT2303021T (lt) 2008-06-16 2019-06-25 University Of Tennessee Research Foundation Junginiai, skirti vėžio gydymui
RU2506260C2 (ru) * 2008-06-25 2014-02-10 Энвиво Фармасьютикалз, Инк. 1,2-дизамещенные гетероциклические соединения
AP2016009182A0 (en) 2013-11-05 2016-04-30 Bayer Cropscience Ag Substituted benzamides for treating arthropodes
US10328064B2 (en) 2014-12-23 2019-06-25 Fgh Biotech, Inc. Compositions of fatostatin based heterocyclic compounds and uses thereof
MX382630B (es) 2016-04-29 2025-03-13 Fgh Biotech Inc Compuestos de pirazol disustituidos para el tratamiento de enfermedades.
EP3510027B1 (en) 2016-09-07 2022-11-02 FGH BioTech, Inc. Di-substituted pyrazole compounds for the treatment of diseases
EP3573957B1 (en) 2017-01-24 2023-04-26 Rivara, Mirko Compositions and methods for blocking sodium channels
CN108191667B (zh) * 2018-01-04 2021-03-26 利尔化学股份有限公司 2-硝基-4-三氟甲基苯甲酸甲酯的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206257A (en) * 1987-03-05 1993-04-27 May & Baker Limited Pesticidal method using 2-phenylimidazole derivatives
JP2630432B2 (ja) * 1987-08-24 1997-07-16 コニカ株式会社 新規なシアンカプラーを含有するハロゲン化銀カラー写真感光材料
JPH01224759A (ja) * 1988-03-03 1989-09-07 Konica Corp 新規なシアンカプラーを含有するハロゲン化銀写真感光材料
JPH01225949A (ja) * 1988-03-04 1989-09-08 Konica Corp ハロゲン化銀写真感光材料
JPH01262546A (ja) * 1988-04-13 1989-10-19 Konica Corp 新規なシアンカプラーを含有するハロゲン化銀写真感光材料
JPH0361946A (ja) * 1989-07-29 1991-03-18 Konica Corp ハロゲン化銀カラー写真感光材料
JPH03245140A (ja) * 1990-02-23 1991-10-31 Konica Corp 新規なシアンカプラーを含有するハロゲン化銀写真感光材料
US5646281A (en) * 1990-12-28 1997-07-08 Neurogen Corporation Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
JPH09304897A (ja) * 1996-05-10 1997-11-28 Konica Corp 新規なシアンカプラーを含有するハロゲン化銀写真感光材料
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
CA2232467A1 (en) * 1997-03-20 1998-09-20 Richard A. Glennon Imidazoles with serotonin receptor binding activity
GB0007405D0 (en) * 2000-03-27 2000-05-17 Smithkline Beecham Corp Compounds

Similar Documents

Publication Publication Date Title
JP2006522820A5 (enExample)
JP2006503048A5 (enExample)
US6090807A (en) Use of heterocyclic compounds
DE69837675T2 (de) Pyrazolderivate
DE69709647T2 (de) Cyclischer diarylalkyl diaminederivate als antogoniste von chemokinerezeptoren
DE3340967C2 (de) Aminderivate, Salze derselben, Verfahren zur Herstellung derselben sowie Anti-Ulcusmittel mit einem Gehalt derselben
DE69418704T2 (de) Anthranilsäure derivate
DE69322254T2 (de) Pyridyl-substituierte imidazole
FI112864B (fi) Menetelmä fluorialkoksilla substituoitujen bentsamidien valmistamiseksi
JP2006512293A5 (enExample)
US20040229927A1 (en) Imidazole derivatives for treatment of allergic and hyperproliferative disorders
DE69722656T2 (de) Bicyclische arylcarboxamide und ihre therapeutische verwendung
RU2003127367A (ru) Бензимидазоловые соединения для модулирования ige и ингибирования клеточной пролиферации
SK282721B6 (sk) Nepeptidové NK3 antagonistické látky, spôsob ich výroby, farmaceutické prostriedky s ich obsahom a ich použitie
JP2005506350A (ja) サイトカイン阻害薬としての1,4−二置換ベンゾ−縮合尿素化合物
RU2009119290A (ru) Производные гидантоина, используемые в качестве ингибиторов ммр
JP2006528617A (ja) 5−ht2b受容体アンタゴニスト
JP2004528304A5 (enExample)
RU2007101501A (ru) Аридзамещенные пиперазиновые производные
DE112012004878T5 (de) Heterocyclische Dihydro-Fünfring-Ketonderivate als DHODH-Inhibitor und ihre Verwendung
EP2447263A1 (en) Benzazole derivatives as histamine H4 receptor ligands
RU2004107854A (ru) Производные 4[пиперидин-4-илиден-(3-карбомоилфенил)метил]бензамида и их применение для лечении боли, спинальных повреждений или желудочно-кишечных расстройств
KR20030085005A (ko) 진양제
RU2003131970A (ru) Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств
JPWO2001036402A1 (ja) 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体